RGS1 and diffuse large B-cell lymphoma: Effects on candidate DLBCL co-driver gene expression were also defined, including Rgs1, an inhibitor of lymphocyte migration (60), and GTPase Rab10, which (like HGAL) is elevated in DLBCL patients with extended OS (61).